Research confirming a lack of standards in hard-to-read prescription drug labeling points to “unacceptable” practices, says the chair of the Senate science committee. A report by the University of Waterloo concluded few drug labels comply with guidelines on size, print and readability: “It is inexcusable”.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
